Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2018
Home
2018
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Repayment of R&D Loan
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Cellmids Evolis Successfully Launched in USA stores
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Trading Halt
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Ikon Legal Action – Decision
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
New Patents for Midkine Antibodies in USA and Europe
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
AGM Presentation to Shareholders
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Results of Annual General Meeting
November 11, 2019
Published by
Tiffany McMillan
on
November 11, 2019
Categories
Appendix 3B and Cleansing Notice
November 4, 2019
Published by
ritzdigi
on
November 4, 2019
Categories
CDY – Cellmid Appoints Exclusive New Zealand Distributor
Prev page
1
2
3
4
5
6
7
8
Next page
